STEPHANIE PHAM: Open Payments
NPI 1144819368 · PALO ALTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$286 in 4 payments from 4 companies in 2025. Trend: 2023 $278 · 2024 $503 · 2025 $286
Food & beverage: $286
| Company | Payments | Amount |
|---|---|---|
| Myriad Genetic Laboratories, Inc. | 1 | $126 |
| ViiV Healthcare Company | 1 | $122 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
Products named: PRECISETUMOR, APRETUDE, BEXSERO, GEMTESA.
Industry payments across CA — which companies pay providers there.
